Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Influenza Hemagglutinin and Neuraminidase Variants

  • Read more about Influenza Hemagglutinin and Neuraminidase Variants
US Application 60/574,553
Filed on 2004-05-25

AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN OF TUMOR NECROSIS FACTOR RECEPTORS

  • Read more about AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN OF TUMOR NECROSIS FACTOR RECEPTORS
US Application 60/717,589
Filed on 2005-09-16

Oxygenation Inhibits The Phsiological Tissue-protecting Mechanism And Thereby Exacerbates Acute Inflammatory Lung Injury

  • Read more about Oxygenation Inhibits The Phsiological Tissue-protecting Mechanism And Thereby Exacerbates Acute Inflammatory Lung Injury
US Application 60/650,267
Filed on 2005-02-04

Optimized Vaccines to Provide Protection against Ebola and other Viruses

  • Read more about Optimized Vaccines to Provide Protection against Ebola and other Viruses
US Application 60/701,694
Filed on 2005-07-22

Method of eliciting an immune response against HIV

  • Read more about Method of eliciting an immune response against HIV
US Application 60/605,187
Filed on 2004-08-27

Poly-gamma-DL-glutamate Capsule Of Staphylococcus Edidermis

  • Read more about Poly-gamma-DL-glutamate Capsule Of Staphylococcus Edidermis
US Application 60/697,646
Filed on 2005-07-08

Methods and Compositions for treating and preventing fibrosis (Wyeth Ref.: AM101991L1)

  • Read more about Methods and Compositions for treating and preventing fibrosis (Wyeth Ref.: AM101991L1)
US Application 60/671,374
Filed on 2005-04-14

AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN (PLAD) OF TUMOR NECROSIS FACTOR RECEPTORS

  • Read more about AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN (PLAD) OF TUMOR NECROSIS FACTOR RECEPTORS
US Application 60/694,015
Filed on 2005-06-24

HIV-Encodes An Si RNA, MicroRNA Sequences and Suppressor of RNA Silencing

  • Read more about HIV-Encodes An Si RNA, MicroRNA Sequences and Suppressor of RNA Silencing
US Application 60/677,839
Filed on 2005-05-05

Identification Of A Cellular Protein That Mediates Cell-to-cell Spread And May Mediate Entry Of Varicella-zoster Into Cells

  • Read more about Identification Of A Cellular Protein That Mediates Cell-to-cell Spread And May Mediate Entry Of Varicella-zoster Into Cells
US Application 60/684,526
Filed on 2005-05-26

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health